Aug 26, 2026 07:30AM
Aug 6, 2026 04:05PM
Jul 30, 2026 04:05PM
Jul 28, 2026 07:30AM
Jun 17, 2026 07:30AM
May 6, 2026 12:49AM
May 5, 2026 04:05PM Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
Apr 30, 2026 04:05PM
Apr 28, 2026 04:05PM
Apr 23, 2026 04:05PM
Apr 1, 2026 07:30AM
Mar 18, 2026 07:52AM
Mar 17, 2026 04:05PM
Mar 10, 2026 04:05PM Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026
Mar 9, 2026 02:20PM
Mar 9, 2026 07:30AM
Mar 9, 2026 07:30AM
Mar 2, 2026 07:30AM
Feb 17, 2026 07:30AM
Jan 22, 2026 12:30PM
Jan 22, 2026 12:30PM Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA)
Jan 8, 2026 07:32AM
Jan 8, 2026 07:30AM
Dec 4, 2025 07:30AM
Dec 4, 2025 07:30AM
Nov 13, 2025 04:05PM
Nov 6, 2025 04:05PM
Nov 4, 2025 07:30AM Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference
Oct 8, 2025 07:30AM
Sep 18, 2025 07:30AM
Sep 18, 2025 07:30AM
Aug 7, 2025 04:05PM
Jun 3, 2025 06:56AM
Jun 3, 2025 06:26AM
Jun 2, 2025 07:00AM Trevi Therapeutics (TRVI) Announces Positive Topline Results from the Phase 2b CORAL Trial
Jun 2, 2025 07:00AM
Mar 19, 2025 06:43AM
Mar 18, 2025 04:05PM
Mar 10, 2025 07:13AM
Mar 10, 2025 06:22AM
Mar 10, 2025 06:00AM
Mar 6, 2025 02:04PM Clear Street Reiterates Buy Rating on Trevi Therapeutics (TRVI)
Dec 3, 2024 04:06PM
Dec 3, 2024 04:05PM
Sep 30, 2024 05:42PM
Sep 30, 2024 05:30PM
May 7, 2024 04:05PM
Oct 13, 2023 08:30AM
Oct 13, 2023 08:30AM Trevi Therapeutics Announces Results from Phase 2b/3 PRISM Open-Label Extension Study of Haduvio™ in Prurigo Nodularis
May 11, 2023 04:05PM

329,911 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All